Localized Pegfilgrastim-induced Neutrophilic Dermatosis with Tissue G-CSF Expression: A Mimicker of Sweet's Syndrome

Acta Derm Venereol. 2019 Jun 1;99(7):685-686. doi: 10.2340/00015555-3170.
No abstract available

Keywords: Sweet’s syndrome; granulocyte-colony stimulating factor; neutrophilic dermatosis; pegfilgrastim.

Publication types

  • Case Reports

MeSH terms

  • Biopsy, Needle
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Breast Neoplasms / surgery
  • Chemotherapy, Adjuvant
  • Diagnosis, Differential
  • Disease Progression
  • Drug Eruptions / etiology*
  • Drug Eruptions / pathology
  • Female
  • Filgrastim / adverse effects*
  • Filgrastim / therapeutic use
  • Granulocyte Colony-Stimulating Factor / metabolism*
  • Humans
  • Immunohistochemistry
  • Leg Dermatoses / chemically induced
  • Leg Dermatoses / pathology
  • Mastectomy / methods
  • Middle Aged
  • Polyethylene Glycols / adverse effects*
  • Polyethylene Glycols / therapeutic use
  • Sweet Syndrome / etiology*
  • Sweet Syndrome / pathology

Substances

  • Granulocyte Colony-Stimulating Factor
  • pegfilgrastim
  • Polyethylene Glycols
  • Filgrastim